CMPX
NASDAQ · Biotechnology
Compass Therapeutics Inc
$2.02
-0.03 (-1.46%)
Open$2.08
Previous Close$2.05
Day High$2.13
Day Low$2.00
52W High$6.88
52W Low$1.61
Volume—
Avg Volume3.46M
Market Cap363.78M
P/E Ratio—
EPS$-0.31
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+2,561.9% upside
Current
$2.02
$2.02
Target
$53.77
$53.77
$36.32
$53.77 avg
$66.75
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.15M | 182.11M | 191.80M |
| Net Income | -66,446,946 | -42,646,254 | -48,286,720 |
| Profit Margin | -5,808.8% | -23.4% | -25.2% |
| EBITDA | -75,469,235 | -49,107,977 | -55,425,546 |
| Free Cash Flow | — | -37,978,554 | -43,960,363 |
| Rev Growth | — | -8.0% | +10.9% |
| Debt/Equity | — | 0.29 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |